A detailed explanation of the quantum sensing technology that enables unprecedented biomarker detection sensitivity.
At the core of this technology is a defect in synthetic diamond: a nitrogen atom positioned next to a missing carbon atom (a "vacancy"). This creates a quantum system with unique properties that allow measurement of magnetic fields with extraordinary precision.
When excited by green laser light, the NV defect emits red fluorescence. By applying precisely timed microwave pulses and measuring how the fluorescence changes, scientists can detect magnetic fields as small as a few nanotesla—roughly 50 million times smaller than Earth's magnetic field.
Imagine a compass so sensitive it can detect the magnetic field of a single atom. That's essentially what an NV diamond sensor does.
This approach is fundamentally different from conventional blood tests, which rely on chemical reactions or light absorption. The magnetic detection method is more sensitive and doesn't require expensive reagents.
Current blood tests can detect biomarkers down to nanogram/milliliter concentrations. NV sensors can detect down to picogram/milliliter—1,000 times more sensitive. This sensitivity gap is critical because many disease markers exist at very low concentrations in early-stage disease, making early detection impossible with conventional methods.
| Detection Method | Sensitivity | Advantage |
|---|---|---|
| Conventional Blood Tests | Nanogram/mL | Established, widely available |
| NV Diamond Sensors | Picogram/mL | 1,000× more sensitive |
| Research Methods | Femtogram/mL | Expensive, time-consuming |
NV diamond sensors are no longer theoretical. Multiple companies are commercializing them:
While the physics is proven, several engineering challenges remain:
These are solvable engineering problems, not fundamental physics limitations. Companies worldwide are actively addressing each of these challenges.